These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29340741)

  • 21. Aspirin Monotherapy Should Not Be Recommended for Cardioprotection in Patients With Symptomatic Peripheral Artery Disease.
    Brass EP; Hiatt WR
    Circulation; 2017 Aug; 136(9):785-786. PubMed ID: 28847795
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antiplatelet strategies in the acute and chronic therapy of cardiovascular disease].
    Schwimmbeck PL
    Med Klin (Munich); 2004 Aug; 99 Suppl 1():8-13. PubMed ID: 15487852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of atherosclerotic carotid artery disease: clinical practice guidelines of the Society for Vascular Surgery.
    Hobson RW; Mackey WC; Ascher E; Murad MH; Calligaro KD; Comerota AJ; Montori VM; Eskandari MK; Massop DW; Bush RL; Lal BK; Perler BA;
    J Vasc Surg; 2008 Aug; 48(2):480-6. PubMed ID: 18644494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of prasugrel for the secondary prevention of atherothrombosis.
    Spinler SA; Rees C
    J Manag Care Pharm; 2009 Jun; 15(5):383-95. PubMed ID: 19496635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty.
    Gremmel T; Xhelili E; Steiner S; Koppensteiner R; Kopp CW; Panzer S
    Atherosclerosis; 2014 Jan; 232(1):119-24. PubMed ID: 24401225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.
    Stone GW; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri E; Gurbel PA; Xu K; Parise H; Kirtane AJ; Brodie BR; Mehran R; Stuckey TD;
    Lancet; 2013 Aug; 382(9892):614-23. PubMed ID: 23890998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for periprocedural antiplatelet therapy, heparinization and bridging of coumarin therapy in carotid revascularization.
    Brand AR; de Borst GJ
    J Cardiovasc Surg (Torino); 2017 Apr; 58(2):143-151. PubMed ID: 28045242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between high on-treatment platelet reactivity and occurrence of cerebral ischemic events in patients undergoing percutaneous coronary intervention.
    Komosa A; Siller-Matula JM; Lesiak M; Michalak M; Kowal J; Mączyński M; Siniawski A; Mularek-Kubzdela T; Wiśniewski S; Grajek S
    Thromb Res; 2016 Feb; 138():49-54. PubMed ID: 26826508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual antiplatelet therapy: optimal timing, management, and duration.
    Sabouret P; Rushton-Smith SK; Kerneis M; Silvain J; Collet JP; Montalescot G
    Eur Heart J Cardiovasc Pharmacother; 2015 Jul; 1(3):198-204. PubMed ID: 27533996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    ; Bittl JA; Baber U; Bradley SM; Wijeysundera DN
    Circulation; 2016 Sep; 134(10):e156-78. PubMed ID: 27026019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there a Role for Oral Triple Therapy in Patients with Acute Coronary Syndromes Without Atrial Fibrillation?
    Spinthakis N; Farag M; Akhtar Z; Gorog DA
    Curr Vasc Pharmacol; 2018; 16(5):427-436. PubMed ID: 29345587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The curative effect comparison of two kinds of therapeutic regimens on decreasing the relative intensity of microembolic signal in CLAIR trial.
    Deng QQ; Tang J; Chen C; Markus H; Huang YN; Zhao H; Ratanakorn D; Wong KS; Fu JH
    J Neurol Sci; 2016 Aug; 367():18-21. PubMed ID: 27423556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of severe bilateral carotid artery stenosis concomitant to severely symptomatic coronary arterial disease requiring coronary artery bypass grafting: a case-based review.
    Hanna EB; Abu-Fadel MS
    J Invasive Cardiol; 2010 Oct; 22(10):E192-6. PubMed ID: 20944197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptomatic bilateral carotid artery stenoses 7 years after coronary artery bypass surgery in a young patient with familial hypercholesterolemia.
    Tok M; Güvener M; Cekirge S; Paşaoglu I
    Vasa; 2008 Feb; 37(1):87-9. PubMed ID: 18512546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS : The end of triple therapy?
    Fluschnik N; Becher PM; Schnabel R; Blankenberg S; Westermann D
    Herz; 2018 Feb; 43(1):20-25. PubMed ID: 29188358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Bittl JA; Baber U; Bradley SM; Wijeysundera DN
    J Am Coll Cardiol; 2016 Sep; 68(10):1116-39. PubMed ID: 27036919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute coronary syndrome, stroke, arterial occlusive disease. Bring the patients out of the danger zone!].
    Füessl HS
    MMW Fortschr Med; 2004; 146 Suppl 1():3. PubMed ID: 15493407
    [No Abstract]   [Full Text] [Related]  

  • 39. Direct Xa inhibitors in addition to antiplatelet therapy in acute coronary syndrome: meta-analysis of randomized trials.
    Villablanca PA; Holmes D; Mohananey D; Briceno DF; Núñez Gil IJ; Kargoli F; Gupta T; Kizer JR; Bortnick AE; Wiley J; Menegus MA; Pyo R; García M; Ramakrishna H; Mookadam F
    Coron Artery Dis; 2017 Aug; 28(5):395-405. PubMed ID: 28328784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current knowledge of the platelet glycoprotein IIb/IIIa receptor antagonists for the treatment of coronary artery disease.
    Berkowitz SD
    Haemostasis; 2000; 30 Suppl 3():27-43. PubMed ID: 11182626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.